Changes in hemodynamic and neurohumoral control cause cardiac damage in one-kidney, one-clip hypertensive mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 6, 2008, Pages

  Borges, Giulianna R ^a   Salgado, Helio C ^a   Silva, Carlos Alberto A ^a   Rossi, Marcos A ^a   Prado, Cibele M ^a   Fazan Jr , Rubens ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Baroreflex; Intrinsic heart rate; Renovascular hypertension; Sympathetic tone; Vagal tone

Indexed keywords

ANGIOTENSIN II; METHYLATROPINE; NEUROHORMONE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEART HEMODYNAMICS; HEART INJURY; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TRANSGENIC MOUSE; VAGUS TONE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; BAROREFLEX; BLOOD PRESSURE; CARDIOMEGALY; CONSTRICTION; DISEASE MODELS, ANIMAL; FIBROSIS; HEART RATE; HEMODYNAMICS; HYPERTENSION, RENOVASCULAR; KIDNEY CORTEX; MALE; MICE; MUSCARINIC ANTAGONISTS; RENAL ARTERY; RENIN; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VAGUS NERVE;

EID: 57749110651     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00107.2008     Document Type: Article

References (46)

1. Bealer SL. Systemic angiotensin II alters intrinsic heart rate through central mechanisms. Brain Res Bull 58: 61-65, 2002.
2. Becker KD, Gottshall KR, Chien KR. Strategies for studying cardiovascular phenotypes in genetically manipulated mice. Hypertension 27: 495-501, 1996.
3. Bertinieri G, Di RM, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. A new approach to analysis of the arterial baroreflex. J Hypertens Suppl 3: S79-S81, 1985.
4. Cabral AM, Vasquez EC. Time course of cardiac sympathetic and vagal tone changes in renovascular hypertensive rats. Am J Hypertens 4: 815-819, 1991.
5. Cervenka L, Horacek V, Vaneckova I, Hubacek JA, Oliverio MI, Coffman TM, Navar LG. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 40: 735-741, 2002.
6. Di Rienzo M, Parati G, Castiglioni P, Tordi R, Mancia G, Pedotti A. Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am J Physiol Regul Integr Comp Physiol 281: R1338-R1340, 2001.
7. Fazan R Jr, Oliveira M, Dias da Silva V, Joaquim LF, Montano N, Porta A, Chapleau MW and Salgado HC. Frequency-dependent baroreflex modulation of blood pressure and heart rate variability in conscious mice. Am J Physiol Heart Circ Physiol 289: H1968-H1975, 2005.
8. Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood) 226: 85-96, 2001.
9. Ferrario CM, Carretero AO. Hemodynamics of experimental renal hypertension. In: Handbook of Hypertension: Experimental and Genetic Models of Hypertension, edited by Jong W. New York: Elsevier Science, 1984, p. 54-80.
10. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005.
11. Gassmann M, Hennet T. From genetically altered mice to integrative physiology. News Physiol Sci 13: 53-57, 1998.
12. Guo GB, Abboud FM. Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol Heart Circ Physiol 246: H80-H89, 1984.
13. Head GA, Adams MA. Time course of changes in baroreceptor reflex control of heart rate in conscious SHR and WKY: contribution of the cardiac vagus and sympathetic nerves. Clin Exp Pharmacol Physiol 15: 289-292, 1988.
14. Head GA, Burke SL. Renal and cardiac sympathetic baroreflexes in hypertensive rabbits. Clin Exp Pharmacol Physiol 28: 972-975, 2001.
15. Hirooka Y, Potts PD, Dampney RA. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res 772: 107-114, 1997.
16. Janssen BJ, Leenders PJ, Smits JF. Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol 278: R215-R225, 2000.
17. Katholi RE, Winternitz SR, Oparil S. Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 3: 404-409, 1981.
18. Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurements of heart rate variability. Cardiol Clin 10: 487-498, 1992.
19. Lanza GA, Guido V, Galeazzi MM, Mustilli M, Natali R, Ierardi C, Milici C, Burzotta F, Pasceri V, Tomassini F, Lupi A, Maseri A. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol 82: 1323-1328, 1998.
20. Laude D, Baudrie V, Elghozi JL. Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice. Am J Physiol Regul Integr Comp Physiol 294: R142-R150, 2008.
21. Lazartigues E, Lawrence AJ, Lamb FS, Davisson RL. Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res 95: 523-531, 2004.
22. Lee WB, Ismay MJ, Lumbers ER. Mechanisms by which angiotensin II affects the heart rate of the conscious sheep. Circ Res 47: 286-292, 1980.
23. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
24. Machado BH, Krieger EM, Salgado HC. Changes of the intrinsic heart rate during the onset of renal hypertension. J Hypertens 5: 755-759, 1987.
25. Machado BH, Salgado HC. Intrinsic heart rate after infusion of angiotensin II in rats with sino-aortic deafferentation. Braz J Med Biol Res 23: 337-341, 1990.
26. Machado BH, Salgado HC, Krieger EM. Tachycardic responses during the development of renal hypertension. Hypertension 5: V122-V127, 1983.
27. Martinka P, Fielitz J, Patzak A, Regitz-Zagrosek V, Persson PB, Stauss HM. Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex. Am J Physiol Regul Integr Comp Physiol 288: R767-R776, 2005.
28. Milan A, Caserta MA, Del CS, Dematteis A, Morello F, Rabbia F, Mulatero P, Pandian NG, Veglio F. Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. J Hypertens 25: 1655-1664, 2007.
29. Mori T, Hashimoto A. Direct positive chronotropic action by angiotensin II in the isolated mouse atrium. Life Sci 79: 637-640, 2006.
30. Moyses MR, Cabral AM, Bissoli N, Vasquez EC. Time course of changes in sigmoidal-fitting baroreceptor curves in one-kidney, one clip hypertensive rats. Hypertension 23: I87-I92, 1994.
31. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316-322, 2002.
32. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5: 93-98, 1987.
33. Peotta VA, Gava AL, Vasquez EC, Meyrelles SS. Evaluation of baroreflex control of heart rate in renovascular hypertensive mice. Can J Physiol Pharmacol 85: 761-766, 2007.
34. Polson JW, Dampney RA, Boscan P, Pickering AE, Paton JF. Differential baroreflex control of sympathetic drive by angiotensin II in the nucleus tractus solitarii. Am J Physiol Regul Integr Comp Physiol 293: R1954-R1960, 2007.
35. Scroop GC, Lowe RD. Efferent pathways of the cardiovascular response to vertebral artery infusions of angiotensin in the dog. Clin Sci 37: 605-619, 1969.
36. Shan ZZ, Dai SM, Su DF. Relationship between baroreceptor reflex function and end-organ damage in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 277: H1200-H1206, 1999.
37. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res 24: 109-121, 1969.
38. Stauss HM, Moffitt JA, Chapleau MW, Abboud FM, Johnson AK. Baroreceptor reflex sensitivity estimated by the sequence technique is reliable in rats. Am J Physiol Heart Circ Physiol 291: H482-H483, 2006.
39. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 28: 709-715, 2001.
40. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci 26: 388-390, 2005.
41. Sun C, Du J, Sumners C, Raizada MK. PI3-kinase inhibitors abolish the enhanced chronotropic effects of angiotensin II in spontaneously hypertensive rat brain neurons. J Neurophysiol 90: 3155-3160, 2003.
42. Sun C, Sumners C, Raizada MK. Chronotropic action of angiotensin II in neurons via protein kinase C and CaMKII. Hypertension 39: 562-566, 2002.
43. Tagawa T, Dampney RA. AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. Hypertension 34: 1301-1307, 1999.
44. Watanabe E, Arakawa T, Uchiyama T, Tong M, Yasui K, Takeuchi H, Terasawa T, Kodama I, Hishida H. Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart Rhythm 4: 999-1005, 2007.
45. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29: 1025-1030, 1997.
46. Zou LX, Hymel A, Imig JD, Navar LG. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 27: 658-662, 1996.